Y Kaya, O Gülcü, E Aksakal, K Kalkan… - Journal of medical …, 2023 - Wiley Online Library
The aim of this study is to investigate the relationship between the model for end‐stage liver disease (MELD) score and disease progression and mortality in COVID‐19 patients. The …
Background The prevalence and outcome of coronavirus disease 2019 (COVID-19) in rural areas is unknown. Methods This is a multi-center retrospective cohort study of hospitalized …
Abstract Background and Aim The impact of the Coronavirus disease‐2019 (COVID‐19) pandemic on patients with liver disease is not well described at the population level in the …
Background COVID-19 patients with neurological manifestations have poorer outcomes. We investigated the association between clinicodemographic and laboratory findings with …
B Paré, M Rozendaal, S Morin, L Kaufmann… - Plos one, 2021 - journals.plos.org
The first confirmed case of COVID-19 in Quebec, Canada, occurred at Verdun Hospital on February 25, 2020. A month later, a localized outbreak was observed at this hospital. We …
JM Reyes-Ruiz, AC Avelino-Santiago… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Coronavirus Disease 2019 (COVID-19) can cause liver injury and a deterioration of hepatic function. The Model for End-Stage Liver Disease (MELD) score is a …
Background The Southeastern rural areas of the USA have a higher prevalence of heart failure (HF). Coronavirus disease 2019 (COVID-19) infection is associated with poor …
B Rajbhandari, S Pant, AB Hamal… - Annals of Medicine …, 2023 - journals.lww.com
Background: Liver impairment has been reported as a common clinical manifestation in patients with Severe Acute Respiratory Syndrome Coronavirus 2 infection, with varying …